In vitro anti-inflammatory effects of hyaluronic acid in ethanol-induced damage in skin cells

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 14, Issue 3, 2011, Pages 425-437

  Neuman, Manuela G ^a,b   Nanau, Radu M ^a,b   Oruña, Loida ^c   Coto, Gabriel ^d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b In Vitro Drug Safety and Biotechnology   (Canada)

^c State Center of Quality and Control of Drug Havana   (Cuba)

^d Placentary Histotherapy Center CHP   (Cuba)

^e CENTRO DE INVESTIGACIÓN Y DESARROLLO DE MEDICAMENTOS CIDEM   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA INTERFERON; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; SKIN CELL;

EID: 82855167334     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3qs3j     Document Type: Article

References (49)

1. Cross SE, Roberts MS. The effect of occlusion on epidermal penetration of parabens from a commercial allergy test ointment, acetone and ethanol vehicles. J Invest Dermatol, 2000; 115:914-918.
2. Rotter ML, Simpson RA, Koller W. Surgical hand disinfection with alcohols at various concentrations: parallel experiments using the new proposed European standards method. Infect Control Hosp Epidemiol, 1998; 19:778-781.
3. Kieć-Swierczyńska M, Krecisz B, Swierczyńska-Machura D. Contact allergy to fragrances. Med Pr, 2006; 57:431-437.
4. Cosmetic Ingredient Review Expert Panel. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate. Int J Toxicol, 2008; 27:S1-S43.
5. Pershing LK, Lambert LD, Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm Res, 1990; 7:170-175.
6. Wu MD, Kimura M, Nakayama M. Inafuku S. A New Treatment Method by Submucosal Ethanol/Steroid (E/S) Injection for Allergic Rhinitis: A Pilot Study. J Aichi Med Univ Assoc, 2007; 35:129-146.
7. Haddock NF, Wilkin JK. Cutaneous reactions to lower aliphatic alcohols before and during disulfiram therapy. Arch Dermatol, 1982; 118:157-159.
8. Bergan JJ, Schmid-Schonbein GW, Coleridge PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. NEJM, 2006; 355:488-498.
9. Brusselaers N, Pirayesh A, Hoeksema H, Richters CD, Verbelen J, Beele H, Blot SI, Monstrey S. Skin replacement in burn wounds. J Trauma, 2010; 68:490-501.
10. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, Gould C, Gemmen E, Dall T. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol, 2006; 55:490-500.
11. Kuehn BM. Chronic wound care guidelines issued. JAMA, 2007; 297:938-939.
12. Medina A, Scott PG, Ghahary A, Tredget EE Pathophysiology of chronic nonhealing wounds. J Burn Care Rehab, 2005; 26:306-319.
13. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev, 2001; 14:244-269.
14. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg, 2004; 187:65S-70S.
15. Sibbald RG, Contreras-Ruiz J, Coutts P, Fierheller M, Rothman A, Woo K Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv Skin Wound Care, 2007; 20:549-558.
16. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N, Givskov M. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen, 2008; 16:2-10.
17. Reddi AH. Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage. J Cell Biochem, 1994; 56:192-195.
18. Papakonstantinou E, Karakiusalakis G, Karakiusalakis G, Roth M, Block L. Platelet-derive growth factor stimuilares the secretion of HA by proliferating human vascular smooth cells. Proc. Natl. Acad. Sci USA, 1995; 92:9881-9885.
19. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 1999; 19:1004-1013
20. Itano N, Kimata K. Mammalian hyaluronan synthases. IUBMB Life, 2002; 54:195-199.
21. Weinstein-Oppenheimer CR, Aceituno AR, Brown DI, Acevedo C, Ceriani R, Fuentes MA, Albornoz F, Henriquez-Roldan CF, Morales P, Maclean C, Tapia SM, Young ME. The effect of an autologous cellular gel-matrix integrated implant system on wound healing. J Transl Med, 2010; 8:59.
22. Neuman MG, Katz G, Malkiewicz I, Mathurin P, Tsukamoto H, Adachi M, Ishii H, Colell A, García-Ruiz C, Fernández-Checa JC, Casey CA. Alcoholic liver injury and apoptosis. Alcohol, 2002a; 28:117-128.
23. Prestwich G.D. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release, 2011; doi:10.1016/j.jconrel.2011.04.007.
24. Namazi MR, Fallahzadeh MK, Schwartz RA. Strategies for prevention of scars: what can we learn from fetal skin? Int J Dermatol, 2011; 50:85-93.
25. Zimmermann DR, Dours-Zimmermann MT, Schubert M, Bruckner-Tuderman L. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol, 1994; 124:817-825.
26. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem, 2004; 279:17079-17084.
27. Shear NH, Malkiewicz IM, Klein D, Koren G, Randor S, Neuman MG. Acetaminophen-induced toxicity to human epidermoid cell line A431 and hepatoblastoma cell line HepG2, in vitro, is diminished by silymarin. Skin Pharmacol. 1995; 8:279-292.
28. Neuman MG, Haber JA, Malkiewicz IM, Cameron RG, Katz GG, Shear NH. Ethanol signals for apoptosis in cultured skin cells. Alcohol, 2002b; 26:179-190.
29. Neuman MG, Oruña L, Coto G, Lago G, Nanau RM, Vincent M. Hyaluronic acid signals for repair in ethanol-induced apoptosis in cultured skin cells. Clin Biochem, 2010; 43:822-826.
30. Neuman MG, Shear NH, Cameron RG, Katz GG, Tiribelli C. Ethanol-induced apoptosis in vitro. Clin Biochem, 1999; 32:547-555.
31. Neuman MG. Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci, 2001; 38:109-166.
32. Katz GG, Shear NH, Malkiewicz IM, Valentino K, Neuman MG. Signaling for ethanol-induced apoptosis and repair in vitro. Clin Biochem, 2001; 34:219-227.
33. Wang J, Chen H, Shankowsky HA, Scott PG, Tredget EE. Improved scar in postburn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial cell growth factor. J Interferon Cytokine Res, 2008; 28:423-434.
34. Matsumoto Y, Arai K, Momose H, Kuroyanagi Y. Development of a wound dressing composed of a hyaluronic acid sponge containing arginine. J Biomater Sci Polym Ed, 2009; 20:993-1004.
35. Parker NP, Bailey SS, Walner DL. Effects of basic fibroblast growth factor-2 and hyaluronic acid on tracheal wound healing. Laryngoscope, 2009; 119:734-739.
36. Iwata Y, Yoshizaki A, Komura K, Shimizu K, Ogawa F, Hara T, Muroi E, Bae S, Takenaka M, Yukami T, Hasegawa M, Fujimoto M, Tomita Y, Tedder TF, Sato S. CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. Am J Pathol, 2009;175:649-660.
37. Kondo T, Shinozaki T, Oku H, Takigami S, Takagishi K. Konjac glucomannan-based hydrogel with hyaluronic acid as a candidate for a novel scaffold for chondrocyte culture. J Tissue Eng Regen Med, 2009; 3:361-367.
38. Sun SF, Chou YJ, Hsu CW, Chen WL. Hyaluronic acid as a treatment for ankle osteoarthritis. Curr Rev Musculoskelet Med, 2009; 2:78-82.
39. Solakoglu S, Tiryaki T, Ciloglu SE. The effect of cultured autologous fibroblasts on longevity of cross-linked hyaluronic acid used as a filler. Aesthet Surg J, 2009; 28:412-416.
40. Park SH, Cui JH, Park SR, Min BH. Potential of fortified fibrin/hyaluronic acid composite gel as a cell delivery vehicle for chondrocytes. Artif Organs, 2009; 33:439-447.
41. Kreger ST, Voytik-Harbin SL. Hyaluronan concentration within a 3D collagen matrix modulates matrix viscoelasticity, but not fibroblast response. Matrix Biol, 2009; 28:336-346.
42. Chung C, Beecham M, Mauck RL, Burdick JA. The influence of degradation characteristics of hyaluronic acid hydrogels on in vitro neocartilage formation by mesenchymal stem cells. Biomaterials, 2009; 30:4287-4296.
43. Molina P, McClain C, Valla D, Guidot D, Diehl AM, Lang C, Neuman M. Molecular pathology and clinical aspects of alcohol induced tissue injury. Alcoholism: Clin and Exper Research, 2002; 26:120-128.
44. Yue XL, Lehri S, Li P, Barbier-Chassefière V, Petit E, Huang QF, Albanese P, Barritault D, Caruelle JP, Papy-Garcia D, Morin C. Insights on a new path of pre-mitochondrial apoptosis regulation by a glycosaminoglycan mimetic. Cell Death Differ, 2009; 16:770-781.
45. Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X, Wei G. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol, 2010; 29:107-116.
46. Lee SE, Jun JE, Choi EH, Ahn SK, Lee SH. Stimulation of epidermal calcium gradient loss increases the expression of hyaluronan and CD44 in mouse skin. Clin Exp Dermatol, 2010; 35:650-657.
47. Ariel A, Lider O, Brill A, Cahalon L, Savion N, Varon D, Hershkoviz R. Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators. Immunology, 2000; 100:345-351.
48. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev, 2011; 91:221-264.
49. Huang TL, Hsu HC, Yang KC, Lin FH. Hyaluronan up-regulates IL-10 expression in fibroblast-like synoviocytes from patients with tibia plateau fracture. J Orthop Res, 2011; 29:495-500.